Advertisment

HUL announces completion of GlaxoSmithKline Consumer Healthcare merger

Board of Directors of HUL have approved HUL acquiring the Horlicks Brand for India from GSK for a consideration of Rs 3,045 crore. The brands which were under the ownership of GSKCH like Boost, Maltova, Viva and others come to HUL's brand portfolio by virtue of the merger

author-image
BestMediaInfo Bureau
New Update
HUL announces completion of GlaxoSmithKline Consumer Healthcare merger

Hindustan Unilever has announced that it has successfully completed the merger of GlaxoSmithKline Consumer Healthcare Limited (GSKCH) with HUL. This merger was announced on December 3, 2018, and was subject to obtaining necessary approvals, which have now been secured. This is one of the largest deals in the FMCG sector in recent times and will lead to significant value creation for all stakeholders.

Call for entries open for BuzzInContent Awards 2020 ENTER NOW

In addition, the Board of Directors of HUL have approved HUL acquiring the Horlicks Brand for India from GSK for a consideration of Euro 375.6 million (Rs 3,045 crore), exercising the option available in the original agreement made between Unilever and GSK. This will enable HUL to utilize cash on its balance sheet and create value for shareholders.

In addition, it will enable HUL to drive better salience in a local context. The other brands which were under the ownership of GSKCH like Boost, Maltova and Viva come to HUL’s brand portfolio by virtue of the merger.

 The merger is in line with HUL’s strategy to build a sustainable and profitable Foods and Refreshment (F&R) business in India by leveraging the megatrend of health and wellness. GlaxoSmithKline Consumer Healthcare Limited is the undisputed leader in the HFD category, with iconic brands such as Horlicks and Boost, and a product portfolio supported by strong nutritional claims. Horlicks, with a volume share of close to 50%, was introduced to India in the 1930s and has been an everyday nutrition staple in households across generations. This merger will bolster HUL’s focus to build a profitable and sustainable Nutrition business in India.

The nutrition and health drinks category remains under-penetrated in India and HUL is well-positioned to further develop the market given the extent of its reach and capabilities.  As shared earlier, HUL will be partnering with GSK (via a consignment selling arrangement) to distribute brands of the GSK Consumer Healthcare family in India. This partnership, with world-class brands from GSK (like Eno, Crocin, Sensodyne etc.) and HUL’s distribution strength can unlock value for GSK and build further Hindustan Unilever’s go-to-market capabilities.

Sanjiv Mehta, Chairman and Managing Director, Hindustan Unilever, said, “Brands such as Horlicks and Boost are iconic, and we are excited to have them in the Hindustan Unilever fold. The merger gives us a unique opportunity to live our purpose and serve India where Nutrition-related challenges form the largest causes of disease– Malnutrition and Micronutrient deficiency - and aligns well with the Government’s ambitious Swasth Bharat and Poshan Abhiyan programs. I am delighted to welcome the 3500 – strong Nutrition Team to the HUL family. Both organizations have common values coming from a lineage of respected parent companies and a shared heritage of building iconic trusted brands.”

Info@BestMediaInfo.com

HUL GlaxoSmithKline Consumer Healthcare
Advertisment